Farmak, one of the largest pharmaceutical producers in Ukraine, was in the center of the new scandal: according to ProZorro platform, the firm sells the Ministry of Defense for injection for injection at a price of 597 UAH per pack - by 40% more expensive than in Ukrainian pharmacies, where the same drug costs.
The military hospital, which has purchased the drugs, is subordinated to the MOU, and therefore it is a purchase of the state budget in the conditions of war. Against the background of a constant shortage of resources, such "commercial" activity looks at least cynically.
Moreover, as journalists noticed, this information suddenly began to disappear from news portals. According to sources, the company allegedly actively cleans public space from negativity, using its own resources and connections.
But this is not the first resonant incident associated with Pharmaco. Previously, investigators reported the facts of the company's products into the territory of the Russian Federation and temporarily occupied territories of Ukraine. According to the investigation, logistics is organized through foreign companies in Moldova, Turkey, Poland and even Belarus.
When crossing the borders, the drugs are allegedly overthrown, the marking changes, and the country of origin is often not indicated at all. Some of the packaging gets a "Russian" appearance - without Ukrainian signs and marking, in fact losing connection with the manufacturer.
Following the publication of these facts, the National Police was submitted. According to the results - opened criminal proceedings №12024000000000953 of 15.05.2025 under Part 1 of Art. 364 of the Criminal Code of Ukraine (abuse of power or office). However, as of now, the investigation has not produced any public result, and the pharmaceutical is continuing its usual mode.
In the conditions of war, when every hryvnia of the state budget must work for defense and conservation of lives, such practices deserve not only condemnation, but also for the immediate reaction of law enforcement and the public.
